Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    19239974 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Fulvestrant in Treating Patients With Recurrent Ovarian Epithelial Cancer
Condition: Ovarian Cancer
Intervention: Drug: Fulvestrant

Indicates status has not been verified in more than two years